Press Releases

Date	Title
6/9/21	Pulse Biosciences Announces Health Canada Approval for CellFX® System
5/24/21	Pulse Biosciences to Participate in the Jefferies Healthcare Conference
5/13/21	Pulse Biosciences® Presents Clinical Study Results of Nano-Pulse Stimulation™ Technology to Clear Benign Lesions at the American Society for Laser Medicine and Surgery (ASLMS) 2021 Virtual Annual Conference
5/10/21	Pulse Biosciences Reports First Quarter 2021 Financial Results
4/26/21	Pulse Biosciences Schedules First Quarter 2021 Financial Results Conference Call for May 10, 2021
4/22/21	Pulse Biosciences to Present Consumer Research on Patient Perceptions of Benign Lesion Clearance at American Academy of Dermatology VMX Meeting 2021
3/5/21	Pulse Biosciences to Participate in Upcoming Investor Conferences
2/22/21	Pulse Biosciences Reports Fourth Quarter and Full Year 2020 Financial Results
2/19/21	Pulse Biosciences Announces First CellFX Procedures Performed in Europe as Part of Global Controlled Launch
2/16/21	Pulse Biosciences Announces Start of Controlled Launch of the CellFX System®

Keyword Search